促炎细胞因子
细胞生物学
血红素
锡克
线粒体ROS
活性氧
TLR4型
信号转导
特里夫
磷酸化
化学
p38丝裂原活化蛋白激酶
生物
MAPK/ERK通路
生物化学
炎症
免疫学
Toll样受体
酪氨酸激酶
先天免疫系统
受体
酶
作者
Elisa Beatriz Prestes,Letícia S. Alves,Danielle A. S. Rodrigues,Fabiano Ferreira,Patricia L. Fernández,Cláudia N. Paiva,Jonathan C. Kagan,Marcelo T. Bozza
出处
期刊:Journal of Immunology
[American Association of Immunologists]
日期:2020-10-09
卷期号:205 (10): 2795-2805
被引量:26
标识
DOI:10.4049/jimmunol.1900886
摘要
Hemolysis causes an increase of intravascular heme, oxidative damage, and inflammation in which macrophages play a critical role. In these cells, heme can act as a prototypical damage-associated molecular pattern, inducing TLR4-dependent cytokine production through the MyD88 pathway, independently of TRIF. Heme promotes reactive oxygen species (ROS) generation independently of TLR4. ROS and TNF production contribute to heme-induced necroptosis and inflammasome activation; however, the role of ROS in proinflammatory signaling and cytokine production remains unknown. In this study, we demonstrate that heme activates at least three signaling pathways that contribute to a robust MAPK phosphorylation and cytokine expression in mouse macrophages. Although heme did not induce a detectable Myddosome formation, the TLR4/MyD88 axis was important for phosphorylation of p38 and secretion of cytokines. ROS generation and spleen tyrosine kinase (Syk) activation induced by heme were critical for most proinflammatory signaling pathways, as the antioxidant N-acetyl-l-cysteine and a Syk inhibitor differentially blocked heme-induced ROS, MAPK phosphorylation, and cytokine production in macrophages. Early generated mitochondrial ROS induced by heme was Syk dependent, selectively promoted the phosphorylation of ERK1/2 without affecting JNK or p38, and contributed to CXCL1 and TNF production. Finally, lethality caused by sterile hemolysis in mice required TLR4, TNFR1, and mitochondrial ROS, supporting the rationale to target these pathways to mitigate tissue damage of hemolytic disorders.
科研通智能强力驱动
Strongly Powered by AbleSci AI